trial
as of 2026-07-01Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
NCTId NCT01338298
at a glance
— · Completed
Enrollment 60 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2016-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
60 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2011-01
Primary completion
2016-12
Eligibility
FEMALE · 18 Years · 50 Years
Interventions & indications
Drugs
Sponsors
University of Maryland, Baltimore CountyLead Sponsor
Investigators
1
Deanna L. Kelly, Pharm.D., BCPPPrincipal Investigator
Sites
1 total
Catonsville, United States
Facts & assertions
4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2016-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator